Published in Stroke on March 01, 1999
Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke (2004) 3.80
Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol (1985) (2008) 3.25
Neuroanatomical substrates of age-related cognitive decline. Psychol Bull (2011) 2.75
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology (2007) 2.40
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology (2007) 2.05
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol (2010) 1.94
White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke (2008) 1.84
Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension (2010) 1.84
Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80
Framingham Stroke Risk Profile and poor cognitive function: a population-based study. BMC Neurol (2008) 1.71
Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk. Brain Res (2009) 1.63
Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation (2010) 1.57
Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron (2013) 1.54
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol (2008) 1.48
Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J Am Geriatr Soc (2007) 1.47
White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol (2013) 1.47
Higher blood pressure predicts lower regional grey matter volume: Consequences on short-term information processing. Neuroimage (2006) 1.40
Subclinical cerebrovascular disease inversely associates with learning ability: The NOMAS. Neurology (2015) 1.38
Measuring cognitive reserve based on the decomposition of episodic memory variance. Brain (2010) 1.35
Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol (2008) 1.33
Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke (2009) 1.32
Brain behavior relationships among African Americans, whites, and Hispanics. Alzheimer Dis Assoc Disord (2008) 1.30
Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol (2007) 1.28
Composite scores for executive function items: demographic heterogeneity and relationships with quantitative magnetic resonance imaging. J Int Neuropsychol Soc (2008) 1.27
Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. Alzheimers Dement (2011) 1.26
Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res (2011) 1.22
Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study. Neurology (2011) 1.22
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). Atherosclerosis (2011) 1.17
Cardiac output as a potential risk factor for abnormal brain aging. J Alzheimers Dis (2010) 1.16
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes. Neurology (2011) 1.13
Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study). Am J Cardiol (2011) 1.12
Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol (2009) 1.11
Long-term exposure to fine particulate matter, residential proximity to major roads and measures of brain structure. Stroke (2015) 1.10
Age and education effects on relationships of cognitive test scores with brain structure in demographically diverse older persons. Psychol Aging (2009) 1.09
Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. Arch Neurol (2010) 1.06
Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with alzheimer disease. Alzheimer Dis Assoc Disord (2008) 1.05
The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol (2010) 1.05
Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study. Stroke (2013) 1.02
An inverse association of cardiovascular risk and frontal lobe glucose metabolism. Neurology (2009) 1.01
Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals. J Alzheimers Dis (2013) 1.01
White matter predictors of cognitive functioning in older adults. J Int Neuropsychol Soc (2012) 0.98
Mixed cerebrovascular disease and the future of stroke prevention. Transl Stroke Res (2012) 0.97
Association of cognitive functioning, incident stroke, and mortality in older adults. Stroke (2014) 0.93
Structural imaging measures of brain aging. Neuropsychol Rev (2014) 0.91
Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study. Cerebrovasc Dis (2014) 0.88
Bivariate heritability of total and regional brain volumes: the Framingham Study. Alzheimer Dis Assoc Disord (2009) 0.88
Associations between total cerebral blood flow and age related changes of the brain. PLoS One (2010) 0.86
Atlas-derived perfusion correlates of white matter hyperintensities in patients with reduced cardiac output. Neurobiol Aging (2009) 0.85
The relationship between executive dysfunction and post-stroke mortality: a population-based cohort study. BMJ Open (2012) 0.85
The impact of hypertension on cerebral perfusion and cortical thickness in older adults. J Am Soc Hypertens (2014) 0.83
Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia. Curr Neuropharmacol (2006) 0.83
Cerebrovascular disease: Assessing the brain as an end-organ of vascular disease. Nat Rev Cardiol (2012) 0.82
Association between neuropathology and brain volume in the Framingham Heart Study. Alzheimer Dis Assoc Disord (2014) 0.82
Characterization of a normal control group: are they healthy? Neuroimage (2013) 0.79
Coronary heart disease and cortical thickness, gray matter and white matter lesion volumes on MRI. PLoS One (2014) 0.79
Cognitive correlates of white matter lesion load and brain atrophy: the Northern Manhattan Study. Neurology (2015) 0.78
A fMRI Study of Verbal Working Memory, Cardiac Output, and Ejection Fraction in Elderly Patients with Cardiovascular Disease. Brain Imaging Behav (2009) 0.77
Aging effects on recollection and familiarity: the role of white matter hyperintensities. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2010) 0.77
Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort. Alzheimers Dement (2016) 0.76
Age Differences in Prefrontal Surface Area and Thickness in Middle Aged to Older Adults. Front Aging Neurosci (2016) 0.76
Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab (2016) 0.75
Midlife exercise blood pressure, heart rate, and fitness relate to brain volume 2 decades later. Neurology (2016) 0.75
Hypertension and risk of death from external causes in the Physicians' Health Study enrollment cohort. Int J Public Health (2010) 0.75
Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study. Stroke (2017) 0.75
Life-course blood pressure in relation to brain volumes. Alzheimers Dement (2016) 0.75
Subclinical Cerebrovascular Disease Increases the Risk of Incident Stroke and Mortality: The Northern Manhattan Study. J Am Heart Assoc (2017) 0.75
Blood Pressure Control in Aging Predicts Cerebral Atrophy Related to Small-Vessel White Matter Lesions. Front Aging Neurosci (2017) 0.75
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03
Genetic influence on smoking--a study of male twins. N Engl J Med (1992) 4.93
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Inverse association of dietary fat with development of ischemic stroke in men. JAMA (1998) 4.20
In vivo nitrate reduction in relation to nitrate uptake, nitrate content, and in vitro nitrate reductase activity in intact barley seedlings. Plant Physiol (1976) 4.16
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
Genetic linkage between hereditary hemochromatosis and HLA. Am J Hum Genet (1979) 3.96
The logopenic/phonological variant of primary progressive aphasia. Neurology (2008) 3.95
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71
Effectiveness of community health workers in the care of persons with diabetes. Diabet Med (2006) 3.66
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology (2010) 3.27
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord (2003) 3.23
Numerical studies on two-loci selection models with general viabilities. Theor Popul Biol (1975) 3.20
Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology (2007) 3.18
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology (2004) 2.97
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91
The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg (1993) 2.91
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87
Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med (1992) 2.77
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol (1993) 2.67
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2007) 2.65
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology (1992) 2.64
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology (2011) 2.61
Direct and indirect gene replacements in Aspergillus nidulans. Mol Cell Biol (1985) 2.61
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med (2000) 2.54
Protective effect of fruits and vegetables on development of stroke in men. JAMA (1995) 2.50
Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology (2009) 2.46
Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45
Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology (2007) 2.43
Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology (1997) 2.43
The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol (1995) 2.42
Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology (2011) 2.42
Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology (2004) 2.37
Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke (1984) 2.30
Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology (2003) 2.28
Apathy is not depression. J Neuropsychiatry Clin Neurosci (1998) 2.24
The natural history of temporal variant frontotemporal dementia. Neurology (2005) 2.22
Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol (2001) 2.22
Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology (1993) 2.21
Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol (1991) 2.20
Chronic disease in former college students. I. Early precursors of fatal coronary heart disease. Am J Epidemiol (1966) 2.18
Functional limitations and disability among elders in the Framingham Study. Am J Public Health (1992) 2.17
StuA is required for cell pattern formation in Aspergillus. Genes Dev (1992) 2.14
Residual disability in survivors of stroke--the Framingham study. N Engl J Med (1975) 2.12
Utah pedigree studies: design and preliminary data for premature male CHD deaths. Prog Clin Biol Res (1979) 2.11
Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology (2005) 2.10
Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology (2007) 2.09
Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology (1998) 2.09
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology (2007) 2.05
Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA (1994) 2.03
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology (1996) 2.00
Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 2.00
Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA (1985) 2.00
Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke (1998) 1.99
Association of parental dementia with cognitive and brain MRI measures in middle-aged adults. Neurology (2009) 1.94
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology (2010) 1.93
A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology (2005) 1.93
Prediction of intracerebral hemorrhage survival. Ann Neurol (1988) 1.92
Visual hallucinations. Clinical occurrence and use in differential diagnosis. West J Med (1987) 1.91
NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care (1997) 1.89
Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88
Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med (1999) 1.86
Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology (2012) 1.81
Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology (2006) 1.80
Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. Arthritis Rheum (1989) 1.80